Your Annual Checkup Blood Panel: Which Tests to Prioritize, What the Numbers Mean, and What Doctors Often Don't Explain

Most people who get annual blood tests receive a result: "Everything looks fine" or "Your cholesterol is a bit high." The underlying values, reference ranges, and clinical reasoning behind these summary assessments are rarely communicated — which means any trends, borderline values, or context-specific concerns are invisible.

This is the case for prioritizing the tests worth running and having some understanding of what they indicate when you get the results yourself.

Metabolic and Hormonal Panel

Fasting glucose: The fundamental metabolic screen. Normal <5.6 mmol/L (100 mg/dL). Prediabetes 5.6–6.9 mmol/L (100–125 mg/dL). A single fasting glucose value misses postprandial dysregulation — HbA1c provides the 3-month integrated view.

HbA1c (glycated hemoglobin): The gold standard metabolic marker. Red blood cells accumulate glucose on their surface over their ~120-day lifespan proportionally to average blood glucose. HbA1c reflects the 3-month average. Normal <5.7%. Prediabetes 5.7–6.4%. Diabetes ≥6.5%. This is more informative than a single fasting glucose for identifying early metabolic dysfunction.

Fasting insulin: Not standard on most checkup panels, but more informative than glucose in early insulin resistance. Fasting insulin rises before fasting glucose does — the pancreas is compensating for insulin resistance by producing more insulin, maintaining normal glucose. Elevated fasting insulin (>12–15 µIU/mL) with normal glucose indicates early IR. Calculate HOMA-IR: (Fasting glucose × Fasting insulin) / 22.5.

> 📌 Facchini et al. (2001) demonstrated that fasting insulin was a stronger predictor of subsequent type 2 diabetes development than fasting glucose — because hyperinsulinemia precedes hyperglycemia by years and represents the compensatory phase before beta-cell exhaustion produces overt glucose dysregulation. [1]

Lipid Panel — Beyond Total Cholesterol

LDL-C: The conventional marker. The LDL particle carrying cholesterol to tissues — relevant to atherosclerotic plaque deposition. However, total LDL-C has significant limitations: it counts large, buoyant LDL particles (less atherogenic) identically to small, dense LDL (more atherogenic).

ApoB: Apolipoprotein B is the protein coat on every atherogenic lipoprotein particle (LDL, VLDL, IDL). Each atherogenic particle carries exactly one ApoB molecule. ApoB directly counts the number of potentially atherogenic particles — more precise than LDL-C, which reflects particle content but not particle number. High ApoB with normal LDL-C is a risk pattern LDL-C misses.

Triglycerides: Elevated (>1.7 mmol/L) reliably indicates either excess carbohydrate intake, insulin resistance, or familial dyslipidemia. A low TG/HDL ratio is associated with insulin sensitivity; elevated TG with low HDL is the dyslipidemia of metabolic syndrome.

HDL-C: The reverse cholesterol transport vehicle. Low HDL (<1.0 mmol/L in men, <1.2 mmol/L in women) is independently predictive of cardiovascular risk.

Organ Function Panel

ALT (alanine aminotransferase): Liver enzyme. Elevated with hepatocyte damage — NAFLD, alcohol, medications, viral hepatitis. The single most useful liver health marker. Reference range varies by laboratory but approximately 7–56 U/L; values consistently above 40 in the absence of acute cause warrant investigation.

Creatinine and eGFR: Kidney function markers. Creatinine is cleared by kidneys — elevated when GFR falls. eGFR (estimated glomerular filtration rate) is calculated from creatinine + age + sex. eGFR > 60 mL/min/1.73 m (5.7 ft)² is normal; below 60 indicates impaired kidney function if confirmed over 3 months.

TSH: Thyroid status (see separate article). Single most sensitive thyroid marker.

Ferritin: The storage form of iron. Low ferritin (iron deficiency) is the most common nutritional deficiency globally and the most common reversible cause of fatigue. Iron deficiency can exist with a normal hemoglobin — ferritin falls before hemoglobin drops. Reference range: 20–200 µg/L (men), 12–150 µg/L (women). Below 30 µg/L frequently produces symptoms.

---

Key Terms

• HbA1c — glycated hemoglobin reflecting 3-month average blood glucose; the diagnostic and monitoring marker for diabetes and prediabetes; more informative than single-point fasting glucose for chronic metabolic status
• ApoB — apolipoprotein B; the protein carried by every atherogenic lipoprotein particle; a more precise cardiovascular risk marker than LDL-C because it counts particle number rather than cholesterol content per particle
• HOMA-IR — homeostatic model assessment of insulin resistance; calculated from fasting glucose and insulin; detects insulin resistance before fasting glucose rises; the earliest biochemical marker of type 2 diabetes in development
• eGFR (estimated glomerular filtration rate) — an estimation of kidney filtration capacity derived from serum creatinine, age, and sex; the primary clinical marker for chronic kidney disease staging

---

Scientific Sources

• 1. Facchini, F.S., et al. (2001). Insulin resistance as a predictor of age-related diseases. Journal of Clinical Endocrinology & Metabolism, 86(8), 3574–3578. PubMed
• 2. Contois, J.H., et al. (2009). Apolipoprotein B and cardiovascular disease risk. Clinica Chimica Acta, 408(1–2), 44–52. PubMed